UTIPRO® PLUS AF strengthens its presence in EUROPE
We are pleased to announce the launch of UTIPRO® PLUS AF in the Republic of Ireland.
UTIPRO® PLUS AF, in its composition free from ingredients of animal origin, has been recently launched in the Republic of Ireland, thus further enlarging its presence across Europe. The product is distributed by Pamex, an Irish company specialized in the detailing and the distribution of high quality and innovative products, mainly addressed to female health and care. Pamex, through its sales force made of 9 dedicated REPS, will introduce the product across Primary, Secondary, Pharmacy & Specialized Care.
UTIPRO® PLUS AF will be available as capsules for oral administration in pharmacies and drug stores in the Republic of Ireland from 11th January 2021.
UTIPRO® PLUS AF is a medical device intended for the control and prevention of urinary tract infections produced by pathogens such as E.coli and other gram (-) bacteria normally involved in the etiology of urological infections.
Utipro® Plus AF is a class IIa medical device and complies with the Essential Requirements of Directive 93/42/EEC and subsequent amendments. (CE 0476, Noventure SL).
